News
news

News Releases

DateSubject
Sep 08, 2010 Medicago announces a single low dose of its H5 VLP Vaccine achieves 100% cross-protection in lethal challenge study in ferrets
Aug 31, 2010 Medicago named in Presidential report on meeting the challenges of pandemic influenza
Aug 19, 2010 Medicago announces closing of its previously announced equity offering for gross proceeds of CAN$7.5 million
Aug 13, 2010 Medicago announces 2010 second quarter financial results
Aug 10, 2010 Medicago announces an increase of its previously announced equity offering to $7.5 million
Aug 10, 2010 Medicago announces $7 million equity offering
Aug 10, 2010 Medicago awarded $21 million from the U.S. Department of Defense
Aug 09, 2010 Medicago Announces a Proposed Offering of Units
Jun 23, 2010 Medicago Selected to Negotiate Final Terms with the Defense Advanced Research Projects Agency for Significant Funding Award
Jun 14, 2010 Medicago signs MOU with PT BIO FARMA for the development of vaccines in the Republic of Indonesia
May 14, 2010 Medicago announces 2010 first quarter financial results
May 13, 2010 Standard & Poor's Announces Changes in the S&P/TSX Venture Composite Index
May 13, 2010 Medicago announces graduation to the TSX and execution of a $10 million standby equity distribution agreement
Apr 23, 2010 Medicago receives conditional approval to graduate to the TSX
Mar 24, 2010 Medicago announces 2009 fourth quarter and year-end financial results
Mar 18, 2010 Medicago announces results of warrant expiry
Mar 16, 2010 Medicago signs MOU with NITT Partners for commercial development of influenza vaccines in Japan
Mar 01, 2010 $300,000 Canadian Institutes of Health Research grant awarded to Medicago, McGill University and the Research Institute of the McGill University Health Centre
Feb 17, 2010 Medicago invited to present at the 6th WHO's meeting on evaluation of pandemic influenza prototype vaccines in clinical trials
Feb 05, 2010 Medicago named to TSX Venture 50
Jan 20, 2010 Medicago provides corporate update